Trial Profile
A pilot study to investigate the effects of pentosan polysulfate sodium in Ross River virus induced arthralgia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2022
Price :
$35
*
At a glance
- Drugs Pentosan polysulfate (Primary)
- Indications Arthralgia; Ross River virus infections
- Focus Adverse reactions
- Acronyms PARA_004
- Sponsors Paradigm Biopharma
- 08 Apr 2019 Status changed from active, no longer recruiting to completed.
- 29 Aug 2018 Planned End Date changed from 10 May 2018 to 20 Nov 2018.
- 29 Aug 2018 Status changed from recruiting to active, no longer recruiting.